Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 538049, 6 pages
http://dx.doi.org/10.1155/2014/538049
Research Article

Age-Dependent Paraoxonase 1 (PON1) Activity and LDL Oxidation in Wistar Rats during Their Entire Lifespan

Department of Biochemistry, University of Allahabad, Allahabad, Uttar Pradesh 211002, India

Received 20 January 2014; Accepted 6 May 2014; Published 22 May 2014

Academic Editor: Alfons López-Soto

Copyright © 2014 Dileep Kumar and Syed Ibrahim Rizvi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Harman, “Free radical theory of aging: an update: increasing the functional life span,” Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 10–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. K. B. Pandey and S. I. Rizvi, “Markers of oxidative stress in erythrocytes and plasma during aging in humans,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 1, pp. 2–12, 2010. View at Google Scholar · View at Scopus
  4. S. A. Nair and T. Rajamohan, “Age dependent variation in the antioxidant status and oxidative stress in rats fed diet containing coconut oil and sunflower oil,” International Journal Of Biological and Medical Research, vol. 3, no. 2, pp. 1589–1594, 2012. View at Google Scholar
  5. F. Amirkhizi, F. Siassi, S. Minaie, M. Djalali, A. Rahimi, and M. Chamari, “Age related alterations in lipid peroxidation and activities of erythrocyte cytoprotective enzymes in women,” ARYA Atherosclerosis, vol. 3, no. 2, pp. 81–86, 2007. View at Google Scholar
  6. H. Esterbauer, M. D. Rotheneder, M. G. Sniegl et al., “Vitamin E and other liphophilic antioxidants protect LDL against oxidation,” European Journal of Lipid Science Technology, vol. 91, no. 8, pp. 316–324, 1989. View at Publisher · View at Google Scholar
  7. D. Steinberg, “The LDL modification hypothesis of atherogenesis: an update,” Journal of Lipid Research, vol. 50, pp. S376–S381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Bandeali and J. Farmer, “High-density lipoprotein and atherosclerosis: the role of antioxidant activity,” Current Atherosclerosis Reports, vol. 14, no. 2, pp. 101–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. N. Durrington, B. Mackness, and M. I. Mackness, “Paraoxonase and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 4, pp. 473–480, 2001. View at Google Scholar · View at Scopus
  10. B. Goswami, D. Tayal, N. Gupta, and V. Mallika, “Paraoxonase: a multifaceted biomolecule,” Clinica Chimica Acta, vol. 410, no. 1-2, pp. 1–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. J. van Lenten, A. C. Wagner, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman, “High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection,” Circulation, vol. 103, no. 18, pp. 2283–2288, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Cherki, H. Berrougui, M. Isabelle, M. Cloutier, G. A. Koumbadinga, and A. Khalil, “Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging,” Experimental Gerontology, vol. 42, no. 8, pp. 815–824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Mehdi and S. I. Rizvi, “Human plasma paraoxonase 1 arylesterase activity during aging: Correlation with Susceptibility of LDL Oxidation,” Archives of Medical Research, vol. 43, no. 6, pp. 438–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ayub, M. I. Mackness, S. Arrol, B. Mackness, J. Patel, and P. N. Durrington, “Serum paraoxonase after myocardial infarction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 2, pp. 330–335, 1999. View at Google Scholar · View at Scopus
  15. E. Schnitzer, I. Pinchuk, A. Bor, M. Fainaru, A. M. Samuni, and D. Lichtenberg, “Lipid oxidation in unfractionated serum and plasma,” Chemistry and Physics of Lipids, vol. 92, no. 2, pp. 151–170, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Szabo, C. Iditoiu, D. Chambre, and A. X. Lupea, “Improved DPPH determination for antioxidant activity spectrophotometric assay,” Chemical Papers, vol. 61, no. 3, pp. 214–216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Esterbauer and K. H. Cheeseman, “Determination of aldehydic lipid peroxidation products: malondialdehyde and 4-hydroxynonenal,” Methods in Enzymology, vol. 186, pp. 407–413, 1990. View at Google Scholar
  18. K. D. Jacob, N. Noren Hooten, A. R. Trzeciak, and M. K. Evans, “Markers of oxidant stress that are clinically relevant in aging and age-related disease,” Mechanisms of Ageing and Development, vol. 134, no. 3-4, pp. 139–157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. P. Deakin and R. W. James, “Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-I,” Clinical Science, vol. 107, no. 5, pp. 435–447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Miura, Y. Sato, Y. Arai et al., “Proteomic analysis of plasma proteins in Japanese semisuper centenarians,” Experimental Gerontology, vol. 46, no. 1, pp. 81–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Hashim and S. Zarina, “Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract,” Clinical Biochemistry, vol. 40, no. 9-10, pp. 705–709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Seres, G. Paragh, E. Deschene, T. Fulop Jr., and A. Khalil, “Study of factors influencing the decreased HDL associated PON1 activity with aging,” Experimental Gerontology, vol. 39, no. 1, pp. 59–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Thomas-Moya, M. Gianotti, I. Llado, and A. M. Proenza, “Effects of caloric restriction and gender on rat serum paraoxonase 1 activity,” The Journal of Nutritional Biochemistry, vol. 17, no. 3, pp. 197–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Berrougui and A. Khalil, “Paraoxonase 1 promotes HDL-mediated cholesterol efflux. Importance of PON1 free sulfhydryls group,” Chemistry and Physics of Lipids, vol. 154, supplement, p. S38, 2008. View at Publisher · View at Google Scholar
  25. T. M. van Himbergen, L. J. H. van Tits, M. P. C. Hectors, J. de Graaf, M. Roest, and A. F. H. Stalenhoef, “Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia,” Biochemical and Biophysical Research Communications, vol. 333, no. 3, pp. 787–793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Schiavon, E. de Fanti, D. Giavarina, S. Biasioli, G. Cavalcanti, and G. Guidi, “Serum paraoxonase activity is decreased in uremic patients,” Clinica Chimica Acta, vol. 247, no. 1-2, pp. 71–80, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Aviram, M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. la Du, “Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase,” The Journal of Clinical Investigation, vol. 101, no. 8, pp. 1581–1590, 1998. View at Google Scholar · View at Scopus
  28. H. Tavori, M. Aviram, S. Khatib et al., “Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284,” Free Radical Biology and Medicine, vol. 50, no. 1, pp. 148–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nishi, H. Itabe, M. Uno et al., “Oxidized LDL in carotid plaques and plasma associates with plaque instability,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1649–1654, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Steinberg, “Oxidative modification of LDL and atherogenesis,” Circulation, vol. 95, no. 4, pp. 1062–1071, 1997. View at Google Scholar
  31. M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce, “OxLDL stimulates cell proliferation through a general induction of cell cycle proteins,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 284, no. 2, pp. H644–H653, 2003. View at Google Scholar · View at Scopus
  32. F. Marchegiani, M. Marra, L. Spazzafumo et al., “Paraoxonase activity and genotype predispose to successful aging,” The Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 61, no. 6, pp. 541–546, 2006. View at Google Scholar · View at Scopus
  33. M. Mackness and B. Mackness, “Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?” Free Radical Biology and Medicine, vol. 37, no. 9, pp. 1317–1323, 2004. View at Publisher · View at Google Scholar · View at Scopus